Cardiff Oncology (CRDF) Short Interest Ratio & Short Volume → Elon Musk’s Next Move Will Disrupt AI Forever (From InvestorPlace) (Ad) Free CRDF Stock Alerts $3.48 +0.09 (+2.65%) (As of 05:17 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Cardiff Oncology Short Interest DataCurrent Short Volume4,420,000 sharesPrevious Short Volume3,990,000 sharesChange Vs. Previous Month+10.78%Dollar Volume Sold Short$19.27 millionShort Interest Ratio / Days to Cover2.3Last Record DateApril 30, 2024Outstanding Shares44,720,000 sharesPercentage of Shares Shorted9.88%Today's Trading Volume341,797 sharesAverage Trading Volume1,399,160 sharesToday's Volume Vs. Average24% Short Selling Cardiff Oncology ? Sign up to receive the latest short interest report for Cardiff Oncology and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCRDF Short Interest Over TimeCRDF Days to Cover Over TimeCRDF Percentage of Float Shorted Over Time Ad InvestorPlaceHave you heard of the $11 AI Coin?A new set of AI startups are rising... Except you won't find them on the stock market.Find out more about this $11 AI Coin right now Cardiff Oncology Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20244,420,000 shares $19.27 million +10.8%N/A2.3 $4.36 4/15/20243,990,000 shares $21.07 million +17.0%N/A2.2 $5.28 3/31/20243,410,000 shares $18.21 million +21.4%N/A2 $5.34 3/15/20242,810,000 shares $14.13 million +144.4%N/A1.8 $5.03 2/29/20241,150,000 shares $2.03 million -3.4%N/A0.9 $1.77 2/15/20241,190,000 shares $2.08 million -7.8%N/A7.6 $1.75 Get the Latest News and Ratings for CRDF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cardiff Oncology and its competitors with MarketBeat's FREE daily newsletter. 1/31/20241,290,000 shares $2.01 million +13.2%N/A7.5 $1.56 1/15/20241,140,000 shares $1.93 million -13.6%N/A6.5 $1.69 12/31/20231,320,000 shares $1.95 million -2.2%N/A6.4 $1.48 12/15/20231,350,000 shares $1.89 million -6.9%N/A2 $1.40 11/30/20231,450,000 shares $1.78 million -9.4%N/A2.1 $1.23 11/15/20231,600,000 shares $1.94 million -1.8%N/A2.3 $1.21 10/31/20231,630,000 shares $1.74 million +6.5%N/A2.2 $1.07 10/15/20231,530,000 shares $1.70 million -24.6%N/A1.4 $1.11 9/30/20232,030,000 shares $2.82 million +201.6%N/A1.9 $1.39 9/15/2023673,000 shares $1.16 million +25.4%N/A1.1 $1.73 8/31/2023536,500 shares $987,160.00 -19.5%N/A0.9 $1.84 8/15/2023666,400 shares $1.33 million +28.7%N/A1.2 $2.00 7/31/2023517,700 shares $916,329.00 +5.0%N/A1 $1.77 7/15/2023492,900 shares $694,989.00 -8.2%N/A3.3 $1.41 6/30/2023537,000 shares $789,390.00 +1.0%N/A3.5 $1.47 6/15/2023531,600 shares $845,244.00 -1.7%N/A3.4 $1.59 5/31/2023541,000 shares $871,010.00 -0.2%N/A2.9 $1.61 5/15/2023542,300 shares $949,025.00 -12.1%N/A2.7 $1.75 4/30/2023616,900 shares $1.07 million -2.4%N/A2.9 $1.74 4/15/2023632,000 shares $941,680.00 +1.2%N/A3 $1.49 3/31/2023624,300 shares $1.03 million -7.3%N/A2.6 $1.65 3/15/2023673,600 shares $1.16 million -1.6%N/A2.6 $1.72 2/28/2023684,400 shares $1.18 million -14.6%N/A2.9 $1.73 2/15/2023801,300 shares $1.50 million -11.6%N/A3.3 $1.87 1/31/2023905,900 shares $1.62 million -9.4%N/A3.6 $1.79 1/15/20231,000,000 shares $1.53 million -8.3%N/A3.9 $1.53 12/30/20221,090,000 shares $1.53 million -5.2%N/A4.6 $1.40 12/15/20221,150,000 shares $1.61 million -2.5%N/A4.4 $1.40 11/30/20221,180,000 shares $1.88 million -1.7%N/A2.3 $1.59 11/15/20221,200,000 shares $1.61 million -7.7%N/A2.2 $1.34 10/31/20221,300,000 shares $2.12 million -19.8%N/A2.2 $1.63 10/15/20221,620,000 shares $2.49 million -10.0%N/A2.6 $1.54 9/30/20221,800,000 shares $2.77 million -18.2%N/A2.7 $1.54 9/15/20222,200,000 shares $3.67 million +9.5%N/A2.5 $1.67He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here CRDF Short Interest - Frequently Asked Questions What is Cardiff Oncology's current short interest? Short interest is the volume of Cardiff Oncology shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,420,000 shares of CRDF short. Learn More on Cardiff Oncology's current short interest. What is a good short interest ratio for Cardiff Oncology? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CRDF shares currently have a short interest ratio of 2.0. Learn More on Cardiff Oncology's short interest ratio. Which institutional investors are shorting Cardiff Oncology? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Cardiff Oncology: Concourse Financial Group Securities Inc., and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Cardiff Oncology's short interest increasing or decreasing? Cardiff Oncology saw a increase in short interest in April. As of April 30th, there was short interest totaling 4,420,000 shares, an increase of 10.8% from the previous total of 3,990,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Cardiff Oncology's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Cardiff Oncology: BioAtla, Inc. (11.08%), Scilex Holding (8.38%), Cardiol Therapeutics Inc. (0.50%), Molecular Partners AG (0.15%), Vaxart, Inc. (10.44%), DBV Technologies S.A. (0.28%), Cellectis S.A. (1.18%), Genfit S.A. (0.18%), Vigil Neuroscience, Inc. (4.61%), Omega Therapeutics, Inc. (22.04%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Cardiff Oncology stock? Short selling CRDF is an investing strategy that aims to generate trading profit from Cardiff Oncology as its price is falling. CRDF shares are trading up $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Cardiff Oncology? A short squeeze for Cardiff Oncology occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CRDF, which in turn drives the price of the stock up even further. How often is Cardiff Oncology's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CRDF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: BioAtla Short Squeeze Scilex Short Squeeze Cardiol Therapeutics Short Squeeze Molecular Partners Short Squeeze Vaxart Short Squeeze DBV Technologies Short Squeeze Cellectis Short Squeeze Genfit Short Squeeze Vigil Neuroscience Short Squeeze Omega Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CRDF) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press